What is ProSomnus Sleep Technologies?
Founded in 2016 and headquartered in Pleasanton, California, ProSomnus Sleep Technologies is a leading manufacturer of precision, patient-preferred Oral Appliance Therapy (OAT) medical devices. These devices are designed for the effective treatment of Obstructive Sleep Apnea (OSA), a common and serious sleep disorder. ProSomnus distinguishes itself through its commitment to patient comfort and device efficacy, positioning its OAT solutions as a preferred alternative for individuals seeking non-invasive sleep apnea management. The company's focus on advanced manufacturing and patient-centric design has been a key driver of its market penetration and recognition within the healthcare technology landscape.
How much funding has ProSomnus Sleep Technologies raised?
ProSomnus Sleep Technologies has raised a total of $50M across 4 funding rounds:
Debt
$1M
Debt
$1M
Private Equity
$10M
Unspecified
$38M
Debt (2020): $1M with participation from PPP
Debt (2021): $1M led by PPP
Private Equity (2023): $10M supported by Spring Mountain Capital and Cetus Capital Partners
Unspecified (2026): $38M featuring Catalio Capital Management
Key Investors in ProSomnus Sleep Technologies
Catalio Capital Management
Catalio Capital Management is a New York-based investment firm specializing in innovative healthcare investing across private, public, and credit markets. They focus on breakthrough biomedical technology companies and leverage a network of venture partners for expert insights.
Spring Mountain Capital
Spring Mountain Capital specializes in growth equity and expansion capital for enterprise technology and healthcare companies. They offer customized investment solutions across various asset classes, with a focus on social impact investing.
Cetus Capital Partners
Cetus Capital Partners provides structured finance and commodity trade finance solutions, leveraging extensive industry experience. They facilitate access to raw materials and offer consulting services across the commodity supply chain.
What's next for ProSomnus Sleep Technologies?
With the recent major strategic investment, ProSomnus Sleep Technologies is well-positioned for its next phase of growth. This capital infusion is expected to fuel advancements in product development, expand manufacturing capabilities, and enhance market reach, both domestically and internationally. The company's strategic focus will likely involve further innovation in oral appliance technology, potentially exploring new materials, digital integration, and personalized treatment protocols. Furthermore, the backing from sophisticated investors suggests a strategic roadmap aimed at scaling operations and capturing a larger share of the rapidly growing sleep disorder treatment market. ProSomnus's trajectory points towards continued leadership in providing effective and patient-preferred solutions for OSA.
See full ProSomnus Sleep Technologies company page
